Gregory T. Lucier - 09 Mar 2026 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role: Director
Signature: /s/ Jessica Nielsen Causey, Attorney-in-Fact for Gregory T. Lucier
Issuer symbol: XRAY
Transactions as of: 09 Mar 2026
Net transactions value: +$186,675
Form type: 4
Filing time: 09 Mar 2026, 16:20:49 UTC
Previous filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
LUCIER GREGORY T	Director	C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Gregory T. Lucier	09 Mar 2026	0001251299

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XRAY	Common Stock	Purchase	$186,675	+15,000	+30%	$12.44	65,000	09 Mar 2026	By a Trust	F1, F2
holding	XRAY	Common Stock						24,901	09 Mar 2026	By Family Partnership
holding	XRAY	Common Stock						21,000	09 Mar 2026	By Gregory Lucier IRA

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F2	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.43 to $12.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.43 to $12.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.